PT3104872T - Paricalcitol para uso no tratamento de anemia inflamatória - Google Patents

Paricalcitol para uso no tratamento de anemia inflamatória

Info

Publication number
PT3104872T
PT3104872T PT15702156T PT15702156T PT3104872T PT 3104872 T PT3104872 T PT 3104872T PT 15702156 T PT15702156 T PT 15702156T PT 15702156 T PT15702156 T PT 15702156T PT 3104872 T PT3104872 T PT 3104872T
Authority
PT
Portugal
Prior art keywords
paricalcitol
treatment
inflammatory anaemia
anaemia
inflammatory
Prior art date
Application number
PT15702156T
Other languages
English (en)
Inventor
Giovanni Uriol Rivera Miguel
Original Assignee
Giovanni Uriol Rivera Miguel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giovanni Uriol Rivera Miguel filed Critical Giovanni Uriol Rivera Miguel
Publication of PT3104872T publication Critical patent/PT3104872T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT15702156T 2014-02-11 2015-01-16 Paricalcitol para uso no tratamento de anemia inflamatória PT3104872T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201430177A ES2472040B1 (es) 2014-02-11 2014-02-11 Uso de paricalcitol en el tratamiento de la anemia inflamatoria

Publications (1)

Publication Number Publication Date
PT3104872T true PT3104872T (pt) 2019-06-11

Family

ID=51205045

Family Applications (1)

Application Number Title Priority Date Filing Date
PT15702156T PT3104872T (pt) 2014-02-11 2015-01-16 Paricalcitol para uso no tratamento de anemia inflamatória

Country Status (16)

Country Link
US (1) US11464791B2 (pt)
EP (1) EP3104872B1 (pt)
JP (1) JP2017512753A (pt)
KR (1) KR20160113664A (pt)
CN (1) CN106061498B (pt)
AR (1) AR099330A1 (pt)
AU (1) AU2015217956B2 (pt)
CA (1) CA2938057A1 (pt)
DK (1) DK3104872T3 (pt)
ES (2) ES2472040B1 (pt)
IL (1) IL247207B (pt)
MX (1) MX365096B (pt)
PT (1) PT3104872T (pt)
RU (1) RU2016131412A (pt)
UY (1) UY35989A (pt)
WO (1) WO2015121022A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022030665A1 (ko) * 2020-08-05 2022-02-10 경상대학교병원 조영제-유발 신독성 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062620A2 (en) * 2003-01-13 2004-07-29 Cedars-Sinai Medical Center Paricalcitol as a chemotherapeutic agent
AU2005235794A1 (en) * 2004-04-23 2005-11-03 Cambridge Antibody Technology Limited Erythropoietin protein variants
EP2101808A4 (en) * 2007-01-10 2011-11-30 Edison Pharmaceuticals Inc TREATMENT OF BREATHLY TROUBLES USING COMPOUNDS OF ERYTHROPOIETIN OR THROMBOPOIETIN ACTIVITY
CN102772364B (zh) * 2011-05-13 2015-12-02 重庆华邦制药有限公司 帕立骨化醇的脂肪乳及其制剂和制备方法

Also Published As

Publication number Publication date
UY35989A (es) 2015-03-27
DK3104872T3 (da) 2019-06-17
MX2016010104A (es) 2017-01-06
JP2017512753A (ja) 2017-05-25
IL247207A0 (en) 2016-09-29
CN106061498B (zh) 2019-12-06
EP3104872B1 (en) 2019-03-13
AU2015217956A1 (en) 2016-08-25
MX365096B (es) 2019-05-22
US20160367571A1 (en) 2016-12-22
CN106061498A (zh) 2016-10-26
KR20160113664A (ko) 2016-09-30
ES2472040R1 (es) 2014-09-18
IL247207B (en) 2020-02-27
ES2472040A2 (es) 2014-06-27
US11464791B2 (en) 2022-10-11
ES2472040B1 (es) 2015-07-01
ES2728158T3 (es) 2019-10-22
AU2015217956B2 (en) 2019-04-04
CA2938057A1 (en) 2015-08-20
EP3104872A1 (en) 2016-12-21
WO2015121022A1 (en) 2015-08-20
RU2016131412A (ru) 2018-03-15
AR099330A1 (es) 2016-07-13

Similar Documents

Publication Publication Date Title
HK1243640A1 (zh) 用於治療潰瘍的方法和組合物
EP3188741A4 (en) Compositions and methods for the treating an inflammatory disease or disorder
IL251905B (en) Epilimod for use in the treatment of kidney cancer
IL251371A0 (en) Cortexolone 17alpha-benzoate for use in the treatment of tumors
IL248767B (en) Trimethoxyphenyl-benzaimidazole compounds for cancer treatment
IL250507B (en) Anti-ck8 antibodies for use in cancer treatment
IL251904B (en) Epilimod for use in the treatment of melanoma
PT3160464T (pt) 6-hidroxibuspirona para uso no tratamento de transtornos do movimento
HK1217913A1 (zh) 阿地米屈在治療上皮功能障礙中的用途
IL249152A0 (en) Botulinum toxin for use in the treatment of paratonia
GB2526391B (en) Improvements in or relating to expansion apparatus
IL247207B (en) Use of pericalcitol in the treatment of inflammatory anemia
HK1217430A1 (zh) 表面處理劑
GB201513543D0 (en) Compositions for use in the treatment of diabetes
ZA201408464B (en) Composition for the use in treatment of asthma
GB201511772D0 (en) Improvements in the treatment of ash
GB201407244D0 (en) Apparatus for use in the manufacture of glass items
GB201415122D0 (en) Apparatus for use in the fashion industry
GB201405898D0 (en) Dressing
GB201404831D0 (en) Animalistic studies in nature
GB201400621D0 (en) The assimilators reduction process